Published in AIDS Weekly, June 11th, 2001
The study is the largest of its kind in a representative cohort of American adult AIDS patients.
"It is fairly clear that the promise of highly active antiretroviral therapy is not deliverable to all patients with HIV," said Raymond T. Chung, MD, from Massachusetts General Hospital, Boston, and senior author of the study. "Liver toxicity is a serious problem irrespective of the class of antiretroviral therapy being given."
Chung made his...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.